Business Combination - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |
2 Months Ended | 3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Feb. 12, 2026 |
Mar. 31, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Business Combination [Line Items] | |||||
| Total revenues | $ 392,911 | $ 306,510 | |||
| Net Income (Loss) | (66,480) | $ 22,464 | |||
| Avadel Pharmaceuticals Plc | |||||
| Business Combination [Line Items] | |||||
| Business combination, price per share | $ 21 | ||||
| Business combination, contingent consideration, additional cash payment per share | $ 1.5 | ||||
| Contingent payments | $ 165,700 | ||||
| Contingent consideration liability | 107,700 | ||||
| Purchase price | 134,900 | ||||
| Recognized share-based compensation expense | 20,200 | ||||
| Total revenues | $ 39,500 | ||||
| Net Income (Loss) | 16,200 | ||||
| Deferred tax liability | 183,129 | 183,100 | 183,100 | ||
| Deferred tax assets | 1,244 | 1,200 | 1,200 | ||
| Transaction costs | $ 34,800 | 34,800 | |||
| Direct one-time transaction costs | $ 77,700 | ||||
| Direct one-time acquisition transaction costs | 44,500 | $ 9,700 | |||
| Acceleration of unvested share-based compensation awards | $ 20,200 | ||||
| X | ||||||||||
- Definition Business combination, contingent consideration, additional cash payment per share. No definition available.
|
| X | ||||||||||
- Definition Business combination, pro forma information, acceleration of unvested share-based compensation awards. No definition available.
|
| X | ||||||||||
- Definition Business combination, pro forma information, direct one-time transaction costs. No definition available.
|
| X | ||||||||||
- Definition Business combination, pro forma information, direct one time acquisition transaction costs. No definition available.
|
| X | ||||||||||
- Definition Business combination, recognized share-based compensation expense. No definition available.
|
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Maximum amount of estimate for undiscounted range of outcomes in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|